NSECertificate under SEBI (Depositories and Participants) Regulations, 20182 Jul 2026 · 2 Jul 2026, 04:28 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Aurobindo Pharma Limited · AUROPHARMA

✦ AI Summary

Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, certifying the details of securities dematerialized/rematerialized during the quarter ended June 30, 2026, have been furnished to all the stock exchanges where the shares of the Company are listed.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

AUROPHARMA_02072026162744_LtrToSEsReg74Compliance30062026.pdf

pdf

Download →
View document text
July 2, 2026 To To Listing Department, The Corporate Relations Department NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED Exchange Plaza, Phiroz Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street, MUMBAI -400 051 MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804 Dear Sir / Madam, Sub: Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This is to certify that the details of securities dematerialized / rematerialized during the quarter ended June 30, 2026, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished to all the stock exchanges where the shares of the Company are listed. The letters confirming this from our RTA - M/s. KFin Technologies Limited dated July 1, 2026, are enclosed for your reference. Further, the certificates of securities which were dematerialized are listed on the Stock Exchanges where earlier issued securities of the Company were listed. Please take the information on record. Thanking you, Yours faithfully, For AUROBINDO PHARMA LIMITED B. Adi Reddy Company Secretary Encl: as above. Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India. Tel: +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044. Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana, India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833 Email: info@aurobindo.com Website: www.aurobindo.com KFIN/APLN/NSDL/74(5) E/1 Date: 01‐07‐2026 NATIONAL SECURITIES DEPOSITORY LIMITED TRADE WORLD 4TH FLOOR KAMALA MILLS COMPOUND SENAPATI BAPAT MARG LOWER PAREL MUMBAI ‐ 400 013 Dear Sir(s), Sub: Certificate under Regulation 74(5) for the quarter ended June 30,2026 We as Registrar to an Issue and Share Transfer Agent of the AUROBINDO PHARMA LIMITED, certify that the details of securities dematerialized/rematerialized during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of the company are listed. Thanking You Yours faithfully, for KFIN TECHNOLOGIES LIMITED C SHOBHA ANAND VICE PRESIDENT CC TO: AUROBINDO PHARMA LIMITED GALAXY, FLOOR 22‐24, PLOT NO. 1, SURVEY HYDERABAD KNOWLEDGE CITY, RAIDURG PANMAK HYDERABAD RANGA REDDY DISTRICT 500032 KFIN/APLN/CDSL/74(5) E/1 Date: 01‐07‐2026 CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED REGD OFF: MARATHON FUTUREX, A WING 25TH FLOOR NM JOSHI MARG LOWER PAREL (EAST) MUMBAI ‐ 400 023 Dear Sir(s), Sub: Certificate under Regulation 74(5) for the quarter ended June 30,2026 We as Registrar to an Issue and Share Transfer Agent of the AUROBINDO PHARMA LIMITED, certify that the details of securities dematerialized/rematerialized during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of the company are listed. Thanking You Yours faithfully, for KFIN TECHNOLOGIES LIMITED C SHOBHA ANAND VICE PRESIDENT CC TO: AUROBINDO PHARMA LIMITED GALAXY, FLOOR 22‐24, PLOT NO. 1, SURVEY HYDERABAD KNOWLEDGE CITY, RAIDURG PANMAK HYDERABAD RANGA REDDY DISTRICT 500032